Purchase Order 75N98026P00328

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation valued at $81,885.40 on June 22, 2018, with ultimate completion on December 21, 2018. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order was a firm fixed price acquisition for scientific instruments, reagents, or consumables typical of Life Technologies' federal supply portfolio supporting research and diagnostic missions.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation for $24,545.41 on August 10, 2016. The order procures various laboratory equipment on a firm fixed price basis. Place of performance is Carlsbad, California. The order is scheduled for completion by September 30, 2016.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Life Technologies Corporation on September 15, 2016, for various laboratory supplies with a firm fixed price of $6,684.06. Performance will occur in Grand Island, New York. The order carries an ultimate completion date of September 19, 2017.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Vanderbilt University for $15,799.25 on June 5, 2020, for animal testing, with completion by September 10, 2020. Performance occurs at Bethesda, Maryland. The order carries firm fixed-price pricing and no set-aside designation.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a $37,343.66 delivery order to Illumina, Inc. on July 10, 2026.</p> <p>Place of performance is Bethesda, MD 20892. No set-aside was used for this order. The order is priced on a firm fixed-price basis with an ultimate completion date of July 10, 2026.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Vanderbilt University on August 19, 2018, with a ceiling value of $9,119.28. This firm-fixed-price purchase order is for obligations related to an expired line item, with a completion date of July 8, 2019. Work is performed in Nashville, Tennessee. No set-aside applies to this award.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Research and Diagnostic Systems, Inc. for $11,681.56 on March 3, 2017. The order was firm fixed price with no set-aside. Performance occurred in Minneapolis, Minnesota. The order expired on May 31, 2017 and procured biological research materials and laboratory supplies, including proteins, antibodies, and assay kits for biomedical research support.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a $12,264 delivery order to Beckman Coulter, Inc. on April 30, 2018, with an ultimate completion date of April 30, 2019. The order is for biomedical laboratory equipment, reagents, software, maintenance, and related services, awarded on a firm fixed price basis with no set-aside. Place of performance is Bethesda, MD.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian federal agency, awarded a $4,491.63 firm fixed-price purchase order to Bioais LLC for the maintenance and repair of a DNA synthesizer located in Catonsville, MD. The period of performance was from January 1, 2010 through December 31, 2010, with a monthly billing of $408.33. This award was not set aside for any specific business type.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Revvity Health Sciences, Inc. for $4,592.16 on November 7, 2014, with completion by November 9, 2015. The order is firm fixed price with no small business set-aside. Work is performed in Shelton, Connecticut. The source does not specify the goods or services procured under this purchase order.</p>